INFLUENCE OF AXIAL LENGTH AND POSTINJECTION REFLUX ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION AS A RESULT OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

被引:15
|
作者
Hoang, Quan V. [1 ,2 ,3 ,4 ]
Jung, Jesse J. [1 ,2 ,3 ,4 ]
Mrejen, Sarah [1 ,2 ]
Freund, K. Bailey [1 ,2 ,3 ,4 ]
机构
[1] Vitreous Retina Macula Consultants New York, New York, NY 10022 USA
[2] Manhattan Eye Ear & Throat Inst, LuEsther T Mertz Retinal Res Ctr, New York, NY USA
[3] Columbia Univ Coll Phys & Surg, Dept Ophthalmol, Edward S Harkness Eye Inst, New York, NY 10032 USA
[4] NYU, Dept Ophthalmol, Med Ctr, New York, NY 10016 USA
关键词
axial; bevacizumab; injection; IOP; length; pressure; ranibizumab; reflux; transient; sustained; MACULAR DEGENERATION; RANIBIZUMAB LUCENTIS; BEVACIZUMAB; INJECTIONS; HYPERTENSION; PEGAPTANIB;
D O I
10.1097/IAE.0000000000000039
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To assess an association of axial length (AL) or postinjection reflux with transient or sustained intraocular pressure (IOP) elevation in patients with neovascular age-related macular degeneration receiving anti-vascular endothelial growth factor injections. Methods: One hundred and forty-seven eyes from 74 consecutive patients with neovascular age-related macular degeneration who presented to a single physician over a 2-month period had ALs measured by IOLMaster. Twenty-one patients had preinjection and immediate postinjection IOP measured and immediate reflux assessed. Results: Overall, 9.5% of eyes had been identified with sustained IOP elevation in our previous study. Axial length did not significantly differ between eyes that had (AL, 23.96 +/- 0.66 mm; n = 14) and had not experienced sustained IOP elevation (AL, 23.44 +/- 1.24 mm; n = 133; P = 0.12, t-test). By linear regression analysis, the relationship between experiencing sustained IOP elevation and AL was not statistically significant (R-2 = 0.0165; P = 0.121). The relationship between AL and immediate postinjection IOP elevation was also not statistically significant (R-2 = 0.0001; P = 0.97). Immediate postinjection IOP increase did differ between eyes without reflux (30.2 +/- 9.3 mmHg; n = 12) and those with reflux (1.1 +/- 7.2; n = 9; P < 0.001). Conclusion: Axial length does not seem to be a predictor of transient or sustained IOP elevation. Repeated trabecular meshwork trauma related to the absence or presence of reflux and immediate postinjection IOP elevation may be a contributing factor.
引用
收藏
页码:519 / 524
页数:6
相关论文
共 50 条
  • [1] Influence of Axial Length and Degree of Injection Reflux on Sustained Intraocular Pressure Elevation Due to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy
    Mendonca, Luis
    Hoang, Quan
    Jung, Jesse
    Mrejen, Sarah
    Freund, K. Bailey
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [2] Predictors of Sustained Intraocular Pressure Elevation in Eyes Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapy
    Yannuzzi, Nicolas A.
    Patel, Samir N.
    Bhavsar, Kavita V.
    Sugiguchi, Fumitaka
    Freund, K. Bailey
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 158 (02) : 319 - 327
  • [3] CLINICAL PREDICTORS OF SUSTAINED INTRAOCULAR PRESSURE ELEVATION DUE TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
    Hoang, Quan V.
    Tsuang, Angela J.
    Gelman, Rony
    Mendonca, Luis S.
    Della Torre, Kara E.
    Jung, Jesse J.
    Freund, K. Bailey
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (01): : 179 - 187
  • [4] EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
    Sisk, Robert A.
    Rusia, Deepam
    Zamora, Brian G.
    Kuley, Alex
    Toussaint, Brian W.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (10): : 1959 - 1964
  • [5] Efficacy of selective laser trabeculoplasty for sustained intraocular pressure elevation following anti-vascular endothelial growth factor therapy
    Jung, Kyungseok
    Adelman, Ron
    Liu, Ji
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [6] Sustained Elevation of Intraocular Pressure After Administration of Intravitreal Anti-Vascular Endothelial Growth Factor Agents in Patients With and Without Pseudoexfoliation Syndrome
    Ucgul, Ahmet Y.
    Aktas, Zeynep
    Ozgur, Armagan
    Cubuk, Mehmet O.
    Hasanreisoglu, Murat
    Ozdek, Sengul
    Gurelik, Gokhan
    [J]. JOURNAL OF GLAUCOMA, 2020, 29 (10) : 981 - 988
  • [7] Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis
    Yandan Zhou
    Minwen Zhou
    Shigang Xia
    Qiancheng Jing
    Ling Gao
    [J]. Scientific Reports, 6
  • [8] Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis
    Zhou, Yandan
    Zhou, Minwen
    Xia, Shigang
    Jing, Qiancheng
    Gao, Ling
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [9] Intraocular Pressure and Anti-Vascular Endothelial Growth Factor Injections
    MacCumber, Mathew W.
    [J]. OPHTHALMOLOGY RETINA, 2020, 4 (09): : 859 - 860
  • [10] Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting
    S. Vo Kim
    F. Fajnkuchen
    V. Sarda
    L. Qu-Knafo
    B. Bodaghi
    A. Giocanti-Aurégan
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 2165 - 2171